EUCTR2019-000326-22-IT进行中(未招募)1 期
The role of Contrast-Enhanced Spectral Mammography (CESM) in the diagnostic process of breast cancer: can it improve specificity of first-line examinations and therefore reduce the suspicious lesions that undergo vacuum assisted breast biopsy (VABB)? - IEO 960
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Woman with suspicious breast lesions from FFDM, US and/or MR imaging and for whom a presurgical evaluation is recommended
- •The subject must be in sufficient good health to be able to undergo standard of care and CESM examinations
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 125
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 45
排除标准
- •The subject is known to have risks of adverse effects with iodine contrast agents.
- •The subject is asymptomatic and without suspicious findings from routine imaging.
- •The subject is participating or has participated (within the prior 30 days) in another clinical
研究者
相似试验
已完成
不适用
Is contrast enhanced spectral mammography (CESM) useful in the investigation of possible abnormalities found on screening mammograms in women with dense breast tissue and does it add useful and important information over and above current standard imaging tests?Cancer - BreastBreast CancerACTRN12616000533493Royal Perth Hospital69
招募中
不适用
Efficacy of contrast enhanced spectral mammography (CESM)JPRN-UMIN000005680Showa University60
招募中
不适用
Can contrast enhanced spectral mammography (CESM) play a clinically useful role in the pre-operative assessment of women with Ductal Carcinoma in Situ (DCIS), the ‘CESM D’ studyDuctal Carcinoma in SituCancer - BreastACTRN12616001696482Clin. Assoc. Prof. Donna Taylor60
已完成
不适用
Clinical study of contrast-enhanced mammography on pre-operative diagnosis of breast cancerBreast cancerJPRN-UMIN000026800Dokkyo Medical University Koshigaya Hospital50
进行中(未招募)
1 期
Role of contrast enhanced mammography with Iomeprol 400 mgI/ml (Iomeron, Bracco), in the identification of breast cancer: I3-MaC StudyMedDRA version: 21.1Level: PTClassification code: 10057654Term: Breast cancer female Class: 100000004864Breast cancerCTIS2024-513251-32-00Azienda Ospedaliero-Universitaria Policlinico Umberto I173
